- Home
- LSTA vs NYC Comparison
LSTA vs NYC Comparison
Compare LSTA & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LSTA | NYC |
|---|---|---|
| Founded | 1980 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Misc Health and Biotechnology Services | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.9M | 24.8M |
| IPO Year | 2000 | 2014 |
Fundamental Metrics
Financial Performance| Metric | LSTA | NYC |
|---|---|---|
| Price | $3.37 | $9.15 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | ★ 61.9K | 38.6K |
| Earning Date | 05-11-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 20.42 | ★ 85.28 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $35,283,868.00 | N/A |
| Revenue This Year | N/A | $56.73 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 56.90 | N/A |
| 52 Week Low | $1.81 | $7.00 |
| 52 Week High | $5.07 | $16.30 |
Technical Indicators
Market Signals| Indicator | LSTA | NYC |
|---|---|---|
| Relative Strength Index (RSI) | 43.36 | 56.95 |
| Support Level | $3.06 | $9.18 |
| Resistance Level | $3.41 | $10.43 |
| Average True Range (ATR) | 0.08 | 0.73 |
| MACD | -0.01 | 0.16 |
| Stochastic Oscillator | 8.82 | 79.13 |
Price Performance
Historical ComparisonAbout LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.